Cutler Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,586
| Closed | -$994K | – | 6742 |
|
|
2021
Q1 | $994K | Sell |
4,586
-4,316
| -48% | -$811K | 0.05% | 449 |
|
|
2020
Q4 | $1.03M | Sell |
8,902
-400
| -4% | -$44.8K | 0.05% | 384 |
|
|
2020
Q3 | $905K | Buy |
9,302
+2,226
| +31% | +$256K | 0.06% | 353 |
|
|
2020
Q2 | $868K | Sell |
7,076
-1,549
| -18% | -$176K | 0.06% | 328 |
|
|
2020
Q1 | $755K | Buy |
8,625
+7,624
| +762% | +$807K | 0.04% | 425 |
|
|
2019
Q4 | $104K | Sell |
1,001
-1,499
| -60% | -$168K | 0.01% | 1185 |
|
|
2019
Q3 | $287K | Buy |
2,500
+1,500
| +150% | +$228K | 0.03% | 543 |
|
|
2019
Q2 | $172K | Sell |
1,000
-652
| -39% | -$113K | 0.02% | 801 |
|
|
2019
Q1 | $278K | Sell |
1,652
-312
| -16% | -$46.4K | 0.03% | 521 |
|
|
2018
Q4 | $191K | Sell |
1,964
-636
| -24% | -$83.4K | 0.02% | 660 |
|
|
2018
Q3 | $449K | Sell |
2,600
-1,203
| -32% | -$173K | 0.03% | 503 |
|
|
2018
Q2 | $530K | Sell |
3,803
-800
| -17% | -$114K | 0.04% | 419 |
|
|
2018
Q1 | $518K | Buy |
4,603
+3,003
| +188% | +$378K | 0.04% | 407 |
|
|
2017
Q4 | $211K | Sell |
1,600
-2,711
| -63% | -$319K | 0.01% | 926 |
|
|
2017
Q3 | $437K | Sell |
4,311
-3,863
| -47% | -$414K | 0.02% | 721 |
|
|
2017
Q2 | $819K | Sell |
8,174
-8,773
| -52% | -$944K | 0.03% | 476 |
|
|
2017
Q1 | $2.05M | Buy |
16,947
+5,517
| +48% | +$677K | 0.09% | 203 |
|
|
2016
Q4 | $1.28M | Buy |
11,430
+10,840
| +1,837% | +$1.3M | 0.05% | 327 |
|
|
2016
Q3 | $78K | Sell |
590
-40,582
| -99% | -$3.88M | ﹤0.01% | 2028 |
|
|
2016
Q2 | $3.77M | Buy |
41,172
+22,091
| +116% | +$1.86M | 0.19% | 76 |
|
|
2016
Q1 | $1.38M | Buy |
19,081
+13,401
| +236% | +$735K | 0.09% | 192 |
|
|
2015
Q4 | $394K | Buy |
+5,680
| New | +$463K | 0.02% | 748 |
|
Other funds holding GWPH
Cutler Group's GWPH Position: Q2 2021 in Review
Cutler Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,586 shares — an estimated $994K sold.
Cutler Group first reported a position in GWPH in Q4 2015 and held it in 22 quarters. The position peaked at $3.77M in Q2 2016. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Cutler Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Cutler Group sold 4,586 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $994K.
- Cutler Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 22 quarters.
- Cutler Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.77M in Q2 2016.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.